Evidence map›Paper›PMID 35166426›Full record

ArticleBJU international2022

Standardised uptake values as determined on prostate-specific membrane antigen positron emission tomography/computed tomography is associated with oncological outcomes in patients with prostate cancer.

Yves J L Bodar, Hans Veerman, Dennie Meijer, Katelijne de Bie, Pim J van Leeuwen, Maarten L Donswijk, R Jeroen A van Moorselaar, N Harry Hendrikse, Ronald Boellaard, Daniela E Oprea-Lager and 1 more

Open access · hybridAbstract read
In one paragraph

Article in BJU international, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
4.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 26 citations in OpenAlex.

  1. Comparison ofProstate cancer and prostatic diseases · 2024
    Pooled it
  2. Article
  3. Impact ofDiagnostics (Basel, Switzerland) · 2025
    Article
  4. Review
  5. Article
  6. PSMA PET/CT SUVmax as a prognostic biomarker in patients with metachronous metastatic hormone-sensitive prostate cancer (mHSPC).Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2025
    Article
  7. Association of [Diagnostics (Basel, Switzerland) · 2025
    Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Quantitative [Scientific reports · 2023
    Article
  13. Higher Preoperative Maximum Standardised Uptake Values (SUVDiagnostics (Basel, Switzerland) · 2023
    Article
  14. European journal of hybrid imaging · 2023
    Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Yves J L BodarDepartment of Urology, Amsterdam University Medical Center, VU University, Amsterdam, the Netherlands.ORCID 0000-0002-2524-2538
Hans VeermanDepartment of Urology, Amsterdam University Medical Center, VU University, Amsterdam, the Netherlands.ORCID 0000-0002-2297-8179
Dennie MeijerDepartment of Urology, Amsterdam University Medical Center, VU University, Amsterdam, the Netherlands.ORCID 0000-0002-8298-575X
Katelijne de BieDepartment of Urology, Amsterdam University Medical Center, VU University, Amsterdam, the Netherlands.
Pim J van LeeuwenProstate Cancer Network The Netherlands, Amsterdam, the Netherlands.
Maarten L DonswijkDepartment of Radiology and Nuclear Medicine, Prostate Cancer Network The Netherlands, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
R Jeroen A van MoorselaarDepartment of Urology, Amsterdam University Medical Center, VU University, Amsterdam, the Netherlands.
N Harry HendrikseDepartment of Radiology & Nuclear Medicine, Amsterdam University Medical Center, VU University, Amsterdam, the Netherlands.
Ronald BoellaardDepartment of Radiology & Nuclear Medicine, Amsterdam University Medical Center, VU University, Amsterdam, the Netherlands.
Daniela E Oprea-LagerDepartment of Radiology & Nuclear Medicine, Amsterdam University Medical Center, VU University, Amsterdam, the Netherlands.
André N VisDepartment of Urology, Amsterdam University Medical Center, VU University, Amsterdam, the Netherlands.
Prostate Cancer UK · GBAmsterdam UMC Location Vrije Universiteit Amsterdam · NLThe Netherlands Cancer Institute · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo investigate the association between intraprostatic, intratumoral maximum standardised uptake values (SUV PATIENTS AND

methodsA bi-centric, secondary analysis of two previous, prospective cohort studies was performed in 318 patients with biopsy confirmed PCa and who were scheduled for RARP. Before surgery, patients received a PSMA PET/CT with either

resultsThe SUV

conclusionIntraprostatic, intratumoral PSMA intensity on PET/CT, as semi-quantitatively expressed by SUV

Indexed as

Positron Emission Tomography Computed TomographyProstatic NeoplasmsGallium IsotopesGallium RadioisotopesHumansMaleProspective StudiesProstateGallium IsotopesGallium Radioisotopes18F-DCFPyL68Ga-PSMA-11biomarkers#PCSMprostate cancer#ProstateCancerstandardised uptake values#uroonc

Identifiers

PMID35166426
PMCPMC9315142
OpenAlexW4213053261

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.